journal article·2022-12-31Open access

Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system

Nour M. AlSawaftah, Vinod Paul, Doua Kosaji, Leen Khabbaz, Nahid S. Awad, Ghaleb A. Husseini

Abstract

Targeted liposomes enable the delivery of encapsulated chemotherapeutics to tumours by targeting specific receptors overexpressed on the surfaces of cancer cells; this helps in reducing the systemic side effects associated with the cytotoxic agents. Upon reaching the targeted site, these liposomes can be triggered to release their payloads using internal or external triggers. In this study, we investigate the use of low-frequency ultrasound as an external modality to trigger the release of a model drug (calcein) from non-targeted and targeted pegylated liposomes modified with cyclic arginine–glycine–aspartate (cRGD). Liposomes were exposed to sonication at 20-kHz using three different power densities (6.2, 9, and 10 mW/cm2). Our results showed that increasing the power density increased calcein release from the sonicated liposomes. Moreover, cRGD conjugation to the surface of the liposomes rendered cRGD-liposomes more susceptible to ultrasound compared to the non-targeted liposomes. cRGD conjugation was also found to increase cellular uptake of calcein by human colorectal carcinoma (HCT116) cells which were further enhanced following sonicating the cells with low-frequency ultrasound (LFUS).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Nanoparticle-Based Drug Delivery · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, College of Engineering, American University of Sharjah, Sharjah, United Arab Emirates

Materials Science and Engineering Program, American University of Sharjah, Sharjah, United Arab Emirates

Funding

American University of Sharjah Faculty Research Grants · Al-Jalila Foundation · Al Qasimi Foundation · Patient’s Friends Committee-Sharjah · Biosciences and Bioengineering Research Institute · GCC Co-Fund Program · Takamul Program · Technology Innovation Pioneer (TIP) Healthcare Awards · Sheikh Hamdan Award for Medical Sciences · Dana Gas Endowed Chair for Chemical Engineering · Material Science and Engineering · Friends of Cancer Patients · American University of Sharjah

References (55)

Show source-provided references
1. 10.20892/j.issn.2095-3941.2017.005210.20892/j.issn.2095-3941.2017.0052 ↗
2. 10.2147/IJN.S14631510.2147/IJN.S146315 ↗
3. 10.1158/1078-0432.CCR-07-144110.1158/1078-0432.CCR-07-1441 ↗
4. 10.2217/nnm.13.11810.2217/nnm.13.118 ↗
5. 10.3390/molecules2304090710.3390/molecules23040907 ↗
6. 10.5772/6138810.5772/61388 ↗
7. 10.2147/DDDT.S21948910.2147/DDDT.S219489 ↗
8. 10.2174/156652401866618041610152210.2174/1566524018666180416101522 ↗
9. 10.1016/j.addr.2018.07.00710.1016/j.addr.2018.07.007 ↗
10. 10.2147/IJN.S125310.2147/IJN.S1253 ↗
11. 10.3390/ijms1901019510.3390/ijms19010195 ↗
12. 10.2217/17435889.1.3.29710.2217/17435889.1.3.297 ↗
13. 10.1016/j.tibtech.2013.09.00710.1016/j.tibtech.2013.09.007 ↗
14. 10.1208/s12248-012-9330-010.1208/s12248-012-9330-0 ↗
15. 10.3389/fonc.2013.0022210.3389/fonc.2013.00222 ↗
16. 10.1016/j.tips.2012.04.00210.1016/j.tips.2012.04.002 ↗
17. 10.1038/nrc274810.1038/nrc2748 ↗
18. 10.3390/ijms14071344710.3390/ijms140713447 ↗
19. 10.3390/cancers909011610.3390/cancers9090116 ↗
20. 10.1097/MJT.000000000000005310.1097/MJT.0000000000000053 ↗
21. 10.1021/la063166810.1021/la0631668 ↗
22. 10.1016/j.chemphyslip.2009.08.00310.1016/j.chemphyslip.2009.08.003 ↗
23. 10.14366/usg.1702110.14366/usg.17021 ↗
24. Torchilin VP, Weissig V. Liposomes: a practical approach. Oxford, Oxford University Press; 2003. p. 396. http://www.tandfonline.com/toc/rwhi20/.10.1093/oso/9780199636556.001.0001 ↗
25. 10.3389/fchem.2018.0051610.3389/fchem.2018.00516 ↗
26. Manjappa AS. Design and characterization of immunoliposomes for site specific delivery of selected anticancer drug. India, University of Vadodara; 2012.
27. 10.1021/acsbiomaterials.8b0130110.1021/acsbiomaterials.8b01301 ↗
28. 10.1081/DIS-10010268410.1081/DIS-100102684 ↗
29. Alsawaftah NM. The use of transferrin and ultrasound in cancer treatment. Sharjah: American University of Sharjah; 2019.
30. 10.1080/21691401.2019.157317510.1080/21691401.2019.1573175 ↗
31. 10.1007/s00280-008-0910-810.1007/s00280-008-0910-8 ↗
32. University of New South Wales. Acoustic impedance intensity and power.
33. 10.1016/j.jconrel.2005.06.01510.1016/j.jconrel.2005.06.015 ↗
34. 10.2147/IJN.S12557310.2147/IJN.S125573 ↗
35. 10.1016/j.ultrasmedbio.2011.11.01710.1016/j.ultrasmedbio.2011.11.017 ↗
36. Cohen-Levi D, Kost J, Barenholz Y. Ultrasound for targeted delivery of cytotoxic drugs from liposomes. Beer Sheva: Ben Gurion University; 2000.
37. 10.1038/s41598-021-86860-510.1038/s41598-021-86860-5 ↗
38. 10.1166/jbn.2021.301210.1166/jbn.2021.3012 ↗
39. 10.1016/j.jconrel.2013.12.01610.1016/j.jconrel.2013.12.016 ↗
40. 10.1016/j.ymeth.2016.07.01510.1016/j.ymeth.2016.07.015 ↗
41. 10.1016/j.addr.2008.03.00710.1016/j.addr.2008.03.007 ↗
42. 10.1016/j.ultrasmedbio.2008.09.00410.1016/j.ultrasmedbio.2008.09.004 ↗
43. 10.1016/0301-5629(91)90125-G10.1016/0301-5629(91)90125-G ↗
44. 10.5152/akd.2015.606110.5152/akd.2015.6061 ↗
45. 10.1161/CIRCRESAHA.108.18380610.1161/CIRCRESAHA.108.183806 ↗
46. 10.1021/acsptsci.0c0021210.1021/acsptsci.0c00212 ↗
47. 10.1038/s41598-021-90349-610.1038/s41598-021-90349-6 ↗
48. 10.1007/s40005-017-0358-010.1007/s40005-017-0358-0 ↗
49. 10.1021/ja952725m10.1021/ja952725m ↗
50. 10.1242/jcs.23122510.1242/jcs.231225 ↗
51. 10.2147/DDDT.S8599310.2147/DDDT.S85993 ↗
52. 10.2147/OTT.S16955510.2147/OTT.S169555 ↗
53. 10.1016/j.jddst.2020.10168710.1016/j.jddst.2020.101687 ↗
54. 10.1016/j.jconrel.2013.04.00710.1016/j.jconrel.2013.04.007 ↗
55. 10.1016/j.jconrel.2012.02.02310.1016/j.jconrel.2012.02.023 ↗